<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Approach to treatment of subacute constrictive pericarditis in adults</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Approach to treatment of subacute constrictive pericarditis in adults</h1>
<div class="graphic"><div class="figure"><div class="ttl">Approach to treatment of subacute constrictive pericarditis in adults</div><div class="cntnt"><img src="data:png;base64,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"/></div><div class="graphic_lgnd">This figure summarizes our suggested general approach to treating subacute constrictive pericarditis in adult patients. Subacute constrictive pericarditis is generally manifested by chest pain, elevated CRP or ESR, pericardial effusion, and pericardial delayed hyperenhancement on CMR in addition to symptoms and signs of pericardial constriction. The treatment approach outlined above does not apply to patients with chronic constrictive pericarditis, which is manifested by anasarca, atrial fibrillation, hepatic dysfunction, and/or pericardial calcification. Refer to UpToDate topics on constrictive pericarditis for additional detail, including guidance on dosing for the medications in this figure and discussion of the evidence supporting their efficacy. Limited data are available on the duration of drug therapies for constrictive pericarditis. Refer to UpToDate topics also for discussion of treatment of effusive-constrictive pericarditis including pericardiocentesis and treatment of specific causes of this condition (eg, tuberculosis, neoplasm, or systemic rheumatic disease).</div><div class="graphic_footnotes"><p>NSAID: nonsteroidal antiinflammatory drug; IL-1: interleukin-1; CRP: serum C-reactive protein level; ESR: erythrocyte sedimentation rate; CMR: cardiovascular magnetic resonance; CCT: cardiac computed tomography.</p>
<p>* For patients with relative or absolute contraindications to NSAID, a glucocorticoid is an alternative to an NSAID. In addition, it is reasonable to proceed directly to treatment with glucocorticoid plus colchicine if the patient has recently been treated with a course of an NSAID plus colchicine (eg, for treatment of acute or recurrent pericarditis).</p>
<p>¶ For patients with prior recurrent or incessant pericarditis, an IL-1 inhibitor is a reasonable alternative to NSAID plus colchicine or glucocorticoid plus colchicine therapy.</p>
<p>Δ Treatment response is assessed by evaluating symptoms and CRP (with or without repeat imaging). A good response is indicated by improvement or resolution of symptoms, reduction or normalization of the CRP, and, if assessed, improvement or resolution of inflammation on CMR or normalization of pericardial thickness on CCT or CMR.</p>
◊ The IL-1 inhibitor used in this setting may be anakinra or rilonacept.</div><div id="graphicVersion">Graphic 141073 Version 1.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
